Related Experiment Video
Updated: Mar 19, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
[Analysis of Factors Contributing to Apheresis Platelet Aggregation]
Xiao-Yan Yu1, Cun-Hao Ma1, Li-Juan Liu1
1Beijing Red Cross Blood Center, Beijing 100088, China.
Objective:
To investigate the influencing factors of apheresis platelet aggregation.
Methods:
Data from platelet collections by using the Amicus blood cell separator between August 2024 and December 2024 were analyzed. The occurrence of platelet aggregation and its contributing factors were analyzed.
Results:
The overall platelet aggregation rate was 16.4%. Aggregation rates in male and female donors were 15.9% and 26.1% , respectively, with no statistically significant difference. Donors with platelet aggregation showed significantly lower HB, HCT, and MCV values but higher Pre-PLT and PCT levels compared to non-aggregated donors. Binary logistic regression analysis revealed that the cause of apheresis platelet aggregation was associated with a history of aggregation and unrelated to other factors. Using aggregation status as the state variable (aggregation=1, non-aggregation=0), the areas under the curve (AUC) for aggregation history, Pre-PLT, and PCT-AUC were 0.784, 0.633, and 0.617, respectively.
Conclusion:
Blood donors who have experienced aggregation are more likely to experience aggregation again. In addition, Special attention should be given to donors with elevated Pre-PLT/PCT levels to avoid the occurrence of serious aggregation, and routine practices should mark donors with platelet aggregation history.
More Related Videos
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

